Pharming (PHAR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $9.36, -2.80% vs the prior close of $9.63.
- Volume 8.92K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PHAR dips 2.8% to $9.36, a 52-week low. Closed at $9.36, -2.80% vs the prior close of $9.63. Day range $9.31–$9.52, opened at $9.50.
PHAR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PHAR dips 2.8% to $9.36, a 52-week low
- Closed at $9.36, -2.80% vs the prior close of $9.63. Day range $9.31–$9.52, opened at $9.50.
- Volume was 8.92K shares, 0.3x its 50-day average of 26.12K — lighter than usual.
- Price is -13.7% vs its 50-day average ($10.85) and -33.7% vs its 200-day average ($14.12).
- 52-week range $9.31–$21.34; today's close sits at 0% of that range, 56.1% below the 52-week high.
Oct 15, 2026 — PHAR ends flat (-0.1%) to $9.63
- Closed at $9.63, -0.10% vs the prior close of $9.64. Day range $9.50–$10.03, opened at $9.50.
- Volume was 7.30K shares, 0.3x its 50-day average of 26.08K — lighter than usual.
- Price is -11.5% vs its 50-day average ($10.88) and -32.0% vs its 200-day average ($14.15).
- 52-week range $9.32–$21.34; today's close sits at 3% of that range, 54.9% below the 52-week high.
Oct 14, 2026 — PHAR rises 2.1% to $9.64
- Closed at $9.64, +2.12% vs the prior close of $9.44. Day range $9.49–$9.64, opened at $9.55.
- Volume was 3.90K shares, 0.1x its 50-day average of 26.21K — lighter than usual.
- Price is -11.6% vs its 50-day average ($10.90) and -32.1% vs its 200-day average ($14.19).
- 52-week range $9.32–$21.34; today's close sits at 3% of that range, 54.8% below the 52-week high.
- SEC filings that day: 6-K.
Oct 13, 2026 — PHAR dips 1.8% to $9.44, a 52-week low
- Closed at $9.44, -1.77% vs the prior close of $9.61. Day range $9.32–$9.62, opened at $9.62.
- Volume was 28.90K shares, 1.1x its 50-day average of 26.31K.
- Price is -13.5% vs its 50-day average ($10.91) and -33.7% vs its 200-day average ($14.23).
- 52-week range $9.32–$21.34; today's close sits at 1% of that range, 55.8% below the 52-week high.
Oct 12, 2026 — PHAR dips 1.8% to $9.61
- Closed at $9.61, -1.84% vs the prior close of $9.79. Day range $9.56–$9.90, opened at $9.90.
- Volume was 7.50K shares, 0.3x its 50-day average of 26.70K — lighter than usual.
- Price is -12.0% vs its 50-day average ($10.92) and -32.7% vs its 200-day average ($14.27).
- 52-week range $9.44–$21.34; today's close sits at 1% of that range, 55.0% below the 52-week high.
Oct 9, 2026 — PHAR rises 2.7% to $9.79
- Closed at $9.79, +2.73% vs the prior close of $9.53. Day range $9.52–$9.85, opened at $9.79.
- Volume was 3.30K shares, 0.1x its 50-day average of 27.62K — lighter than usual.
- Price is -10.4% vs its 50-day average ($10.93) and -31.6% vs its 200-day average ($14.31).
- 52-week range $9.44–$21.34; today's close sits at 3% of that range, 54.1% below the 52-week high.
Oct 8, 2026 — PHAR dips 1.2% to $9.53, a 52-week low, 3 down days in a row
- Closed at $9.53, -1.24% vs the prior close of $9.65. Day range $9.44–$9.77, opened at $9.65.
- Volume was 5.10K shares, 0.2x its 50-day average of 27.59K — lighter than usual.
- Price is -13.0% vs its 50-day average ($10.95) and -33.6% vs its 200-day average ($14.35).
- 52-week range $9.44–$21.34; today's close sits at 1% of that range, 55.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — PHAR dips 0.3% to $9.65, a 52-week low
- Closed at $9.65, -0.31% vs the prior close of $9.68. Day range $9.59–$9.75, opened at $9.65.
- Volume was 3.80K shares, 0.1x its 50-day average of 27.59K — lighter than usual.
- Price is -12.3% vs its 50-day average ($11.00) and -32.9% vs its 200-day average ($14.39).
- 52-week range $9.59–$21.34; today's close sits at 1% of that range, 54.8% below the 52-week high.
Oct 6, 2026 — PHAR dips 1.2% to $9.68, a 52-week low
- Closed at $9.68, -1.22% vs the prior close of $9.80. Day range $9.68–$9.86, opened at $9.86.
- Volume was 6.70K shares, 0.2x its 50-day average of 27.57K — lighter than usual.
- Price is -12.5% vs its 50-day average ($11.06) and -32.9% vs its 200-day average ($14.42).
- 52-week range $9.62–$21.34; today's close sits at 1% of that range, 54.6% below the 52-week high.
Oct 5, 2026 — PHAR rises 0.5% to $9.80
- Closed at $9.80, +0.51% vs the prior close of $9.75. Day range $9.74–$10.08, opened at $9.75.
- Volume was 10.80K shares, 0.4x its 50-day average of 27.47K — lighter than usual.
- Price is -12.0% vs its 50-day average ($11.13) and -32.2% vs its 200-day average ($14.46).
- 52-week range $9.62–$21.34; today's close sits at 2% of that range, 54.1% below the 52-week high.
Oct 2, 2026 — PHAR dips 2.0% to $9.75, a 52-week low, 4 down days in a row
- Closed at $9.75, -2.01% vs the prior close of $9.95. Day range $9.75–$9.96, opened at $9.95.
- Volume was 12.20K shares, 0.4x its 50-day average of 27.27K — lighter than usual.
- Price is -12.8% vs its 50-day average ($11.19) and -32.7% vs its 200-day average ($14.49).
- 52-week range $9.62–$21.34; today's close sits at 1% of that range, 54.3% below the 52-week high.
- That makes 4 straight losses.
PHAR latest news & SEC filings
Every SEC filing by or about PHAR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade PHAR
- How much it moves: over the last 20 sessions the average daily move was 1.85% (largest 4.8%).
- Liquidity: about 31.10K shares (≈$291.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $9.36 vs a range of $9.31–$21.34 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 14, 2026; 6-K Sep 29, 2026; 6-K Sep 25, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PHAR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9.50 | 9.52 | 9.31 | 9.36 | 8.92K |
| Oct 15, 2026 | 9.50 | 10.03 | 9.50 | 9.63 | 7.30K |
| Oct 14, 2026 | 9.55 | 9.64 | 9.49 | 9.64 | 3.90K |
| Oct 13, 2026 | 9.62 | 9.62 | 9.32 | 9.44 | 28.90K |
| Oct 12, 2026 | 9.90 | 9.90 | 9.56 | 9.61 | 7.50K |
| Oct 9, 2026 | 9.79 | 9.85 | 9.52 | 9.79 | 3.30K |
| Oct 8, 2026 | 9.65 | 9.77 | 9.44 | 9.53 | 5.10K |
| Oct 7, 2026 | 9.65 | 9.75 | 9.59 | 9.65 | 3.80K |
| Oct 6, 2026 | 9.86 | 9.86 | 9.68 | 9.68 | 6.70K |
| Oct 5, 2026 | 9.75 | 10.08 | 9.74 | 9.80 | 10.80K |
| Oct 2, 2026 | 9.95 | 9.96 | 9.75 | 9.75 | 12.20K |
| Oct 1, 2026 | 10.08 | 10.15 | 9.95 | 9.95 | 12.10K |
| Sep 30, 2026 | 10.16 | 10.28 | 9.99 | 9.99 | 12.30K |
| Sep 29, 2026 | 10.17 | 10.23 | 10.00 | 10.01 | 26.30K |
| Sep 28, 2026 | 10.46 | 10.70 | 10.33 | 10.52 | 15.50K |
| Sep 25, 2026 | 10.42 | 11.15 | 10.25 | 10.46 | 128.50K |
| Sep 24, 2026 | 10.59 | 10.64 | 10.36 | 10.44 | 31.70K |
| Sep 23, 2026 | 11.00 | 11.06 | 10.65 | 10.77 | 28.60K |
| Sep 22, 2026 | 11.11 | 11.48 | 10.99 | 11.26 | 51.30K |
| Sep 21, 2026 | 10.50 | 11.50 | 10.50 | 10.81 | 217.30K |
About Pharming
Pharming (PHAR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LEIDEN, Netherlands. State of incorporation: Netherlands. Fiscal year ends December 31. SEC CIK 1828316.
PHAR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PHAR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PHAR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PHAR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.